Skip to content

SORELECO

Active
Private limited companyfounded 20205 yrs activeDr.Decrolylaan 54, 1180 Ukkel, BelgiumKBO/BCE: BE 0755.514.687

SORELECO has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €397k and a net result of €198k. Equity is growing by ~51.2% per year across the filed fiscal years. Its solvency ranks better than 86% of 16414 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
100 / 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability94
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 12.93 against 4.39 in 2024), and 7.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
92.3%
Return on assets
46%
Age of the figures
18 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 01-10-2025, 30 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
30 d early
2024
34 d early
2023
28 d early
2022
25 d early
2021
5 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven months
Position in the running window
31-03-2026 close15-09-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€198k▲ 12.3%
2024 · €176k
2021: €174k 2022: €175k 2023: €164k 2024: €176k
2021 → 2025
Working capital
€396k▲ 55.0%
2024 · €256k
2021: €122k 2022: €95k 2023: €142k 2024: €256k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€118k-€100k▼ 15.4%€149k▲ 49.2%€259k▲ 74.2%€397k▲ 53.3%
Operating result€226k-€217k▼ 4.0%€198k▼ 8.6%€235k▲ 18.6%€259k▲ 10.4%
Net result€174k-€175k▲ 0.5%€164k▼ 6.1%€176k▲ 7.5%€198k▲ 12.3%
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €226k€226kNet result 2021: €174k€174kOperating result 2022: €217k€217kNet result 2022: €175k€175kOperating result 2023: €198k€198kNet result 2023: €164k€164kOperating result 2024: €235k€235kNet result 2024: €176k€176kOperating result 2025: €259k€259kNet result 2025: €198k€198k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 10% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €431k
Fixed assets €1k▼ 63.6%
Current assets €429k▲ 29.7%
Equity and liabilities €431k
Equity €397k▲ 53.3%
Debt €33k▼ 55.8%
The debt ratio falls from 22.5% to 7.7%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€261k
2024 · €238k
Cash flow
€200k
2024 · €179k
Solvency
92.3%
2024 · 77.5%
Current ratio
12.93
2024 · 4.39
Quick ratio
12.93
2024 · 4.39
Debt / equity
0.08
2024 · 0.29
ROE
49.9%
2024 · 68.0%
ROA
46.0%
2024 · 52.7%
Interest coverage
366.68
2024 · 1315.71
Debt
€33k
2024 · €75k
Debt ≤ 1 year
€33k
2024 · €75k
Income taxes
€60k
2024 · €58k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€335k€431k
Fixed assets21/28€4k€1k
Tangible fixed assets22/27€4k€1k
Furniture and vehicles24€2k€106
Other tangible fixed assets26€2k€1k
Financial fixed assets28€105€105=
Current assets29/58€331k€429k
Amounts receivable within one year40/41-€393
Other amounts receivable41-€393
Current investments50/53-€250k
Cash at bank and in hand54/58€329k€175k
Deferred charges and accrued income490/1€2k€4k
Equity and liabilities
Total equity and liabilities10/49€335k€431k
Equity10/15€259k€397k
Contributions10/11€4k€4k=
Reserves13€254k€392k
Distributable reserves133€254k€392k
Profit (loss) carried forward14€2k€2k
Amounts payable17/49€75k€33k
Amounts payable within one year42/48€75k€33k
Trade debts44€4k€5k
Suppliers440/4€4k€5k
Taxes, remuneration and social security45€68k€14k
Taxes450/3€68k€14k
Other amounts payable47/48€3k€14k
Accrued charges and deferred income492/3-€122
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€1k
Other operating charges640/8€169€196
Gross operating margin9900€238k€261k
Operating profit (loss)9901€235k€259k
Financial income75/76B-€59
Recurring financial income75-€59
Financial charges65/66B€181€711
Recurring financial charges65€181€711
Profit (loss) for the period before taxes9903€235k€259k
Income taxes67/77€58k€60k
Profit (loss) for the period9904€176k€198k
Profit (loss) for the period to be appropriated9905€176k€198k
Appropriation of the result
Profit (loss) to be appropriated9906€178k€200k
Profit (loss) brought forward from the previous period14P€1k€2k
Transfer from equity791/2€66k-
Transfer to equity691/2€176k€138k
To other reserves6921€176k€138k
Profit to be distributed694/7€66k€60k
Return on contributions (dividend)694€66k€60k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2025
01-10
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial Highest result since 2021net €198k ▲12.3%
Operating result €259k, net result €198k, both a record.
31-03
Financial Liquidity triplescurrent ratio 12.93
Current ratio from 4.39 to 12.93; short-term debt falls from €75k to €33k.
2024
27-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
31-03
Financial Equity above €200kEq €259k ▲74.2%
4 profitable years in a row build equity to €259k.
2023
03-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
31-03
Financial Weakest financial yearnet €164k ▼6.1%
Net result drops to €164k, the lowest in the series; recovery starts the following year.
31-03
Financial Equity above €100kEq €149k ▲49.2%
3 profitable years in a row build equity to €149k.
2022
06-10
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2021
26-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2020
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Dr.Decrolylaan 541180 Ukkel
1 establishment unit
Dr.Decrolylaan 54, 1180 Ukkel
Specialist medical practice
since 20202.309.734.603

Similar companies · same sector, comparable size

Of 157 companies in sector 86101 we hold annual accounts for 81. 27 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded01-10-2020
Fiscal year end31-03
Activities, NACEBEL
86101Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filings

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
E-mail:renaud.leloup@gmail.com
Establishment Ukkel 2.309.734.603